Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$480,555,266
+$140,680,937 QoQ
Shares Held
400,653
+8.4% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#150
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 55%
Shared 1%
None 44%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2024CallValue
$6,790,350
CallShares
7,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUIST FINANCIAL CORP holds $2,652,531,465 across 15 Drug Manufacturers - General names. LLY ranks #3 (18.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
2,519,569 | $634,024,342 | |
| 2 | JNJ |
Johnson & Johnson
|
2,173,861 | $552,095,477 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
400,653 | $480,555,266 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,308,510 | $296,643,534 | |
| 5 | NVS |
Novartis AG
|
968,701 | $151,814,820 | |
| 6 | AZN |
Astrazeneca PLC
|
797,497 | $151,221,380 | |
| 7 | AMGN |
Amgen Inc
|
394,190 | $142,744,081 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,277,343 | $73,600,502 |
All Filings in LLY
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $480,555,266 | 400,653 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $339,874,329 | 369,521 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $394,157,195 | 366,767 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $272,683,229 | 357,383 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $293,943,612 | 377,078 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $307,240,996 | 372,003 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $283,158,792 | 366,786 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $318,649,582 | 359,674 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,790,350 | 7,500 | Call | Defined | 2024-08-21 | |
| 2024-06-30 | $318,393,172 | 351,668 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $243,951,139 | 313,578 | Shares | Defined | 2024-05-13 | |
| 2024-03-31 | $5,834,700 | 7,500 | Call | Defined | 2024-05-13 | |
| 2023-12-31 | $158,573,474 | 272,033 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $165,213,665 | 307,586 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $108,986,730 | 232,391 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $83,588,771 | 243,401 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $89,310,688 | 244,125 | Shares | Defined | 2023-02-17 | |
| 2022-09-30 | $75,908,998 | 234,758 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $76,950,478 | 237,333 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $73,868,853 | 257,949 | Shares | Defined | 2022-04-22 | |
| 2021-12-31 | $72,760,489 | 263,415 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $59,415,893 | 257,156 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $57,815,628 | 251,898 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $48,452,325 | 259,353 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $43,048,964 | 254,969 | Shares | Defined | 2021-11-19 | |
| 2020-09-30 | $39,324,025 | 265,667 | Shares | Defined | 2021-11-05 | |
| 2020-06-30 | $52,322,029 | 318,687 | Shares | Defined | 2021-11-16 | |
| 2020-03-31 | $42,682,338 | 307,687 | Shares | Defined | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||